| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bausch & Lomb Corp | CEO & Chairman, Director | Non-Qualified Stock Options (right to purchase) | 1.87M | $33.6M | $17.96 | May 5, 2022 | Direct |
| Bausch Health Companies Inc. | Director | Common Shares, No Par Value | 1.43M | $11.4M | $8.02 | May 10, 2022 | Direct |
| Bausch & Lomb Corp | CEO & Chairman, Director | Common Shares, No Par Value | 472K | $8.06M | $17.06 | May 5, 2022 | Direct |
| Emergent BioSolutions Inc. | President and CEO, Director | Common Stock | 343K | $2M | $5.83 | May 13, 2025 | Direct |
| Candel Therapeutics, Inc. | Director | Common Stock | 64.2K | $300K | $4.67 | Jun 25, 2025 | By Joseph C. Papa Revocable Living Trust |
| Candel Therapeutics, Inc. | Director | Common Stock | 38K | $183K | $4.81 | Jun 25, 2025 | Direct |
| Milestone Pharmaceuticals Inc. | Director | Common Shares | 100K | $120K | $1.20 | Jul 11, 2025 | Direct |
| Emergent BioSolutions Inc. | President and CEO, Director | Employee Stock Options (Right to Buy) | 1.53M | Mar 12, 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Director | Series A Common Warrants (right to buy) | 100K | Jul 11, 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Director | Series B Common Warrants (right to buy) | 100K | Jul 11, 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 40K | Jun 10, 2025 | Direct | ||
| Candel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.2K | Jun 17, 2025 | Direct | ||
| Bausch Health Companies Inc. | Director | Restricted Share Units | 0 | $9.40 | May 10, 2022 | Direct | |
| Prometheus Biosciences, Inc. | Director | Common Stock | 0 | $108.42 | Jun 16, 2023 | By The Papa Family Charitable Trust | |
| Prometheus Biosciences, Inc. | Director | Common Stock | 0 | $108.42 | Jun 16, 2023 | Direct | |
| Prometheus Biosciences, Inc. | Director | Stock Option (right to buy) | 0 | Jun 16, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc. | Jul 11, 2025 | 3 | $0 | 4 | Jul 15, 2025 | Director |
| CADL | Candel Therapeutics, Inc. | Jun 25, 2025 | 1 | $300K | 4 | Jun 26, 2025 | Director |
| CADL | Candel Therapeutics, Inc. | Jun 17, 2025 | 1 | $0 | 4 | Jun 18, 2025 | Director |
| MIST | Milestone Pharmaceuticals Inc. | Jun 10, 2025 | 1 | $0 | 4 | Jun 12, 2025 | Director |
| EBS | Emergent BioSolutions Inc. | May 13, 2025 | 1 | $350K | 4 | May 15, 2025 | President and CEO, Director |
| EBS | Emergent BioSolutions Inc. | Mar 12, 2025 | 2 | $0 | 4 | Mar 12, 2025 | President and CEO, Director |
| EBS | Emergent BioSolutions Inc. | Mar 6, 2025 | 2 | $0 | 4 | Mar 10, 2025 | President and CEO, Director |
| MIST | Milestone Pharmaceuticals Inc. | Sep 3, 2024 | 1 | $0 | 4 | Sep 5, 2024 | Director |
| MIST | Milestone Pharmaceuticals Inc. | Sep 3, 2024 | 0 | $0 | 3 | Sep 5, 2024 | Director |
| CADL | Candel Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| EBS | Emergent BioSolutions Inc. | Mar 13, 2024 | 1 | $0 | 4 | Mar 15, 2024 | President and CEO, Director |
| EBS | Emergent BioSolutions Inc. | Feb 21, 2024 | 0 | $0 | 3 | Feb 29, 2024 | President and CEO, Director |
| CADL | Candel Therapeutics, Inc. | Jun 28, 2023 | 1 | $0 | 4 | Jun 29, 2023 | Director |
| RXDX | Prometheus Biosciences, Inc. | Jun 16, 2023 | 7 | $0 | 4 | Jun 16, 2023 | Director |
| RXDX | Prometheus Biosciences, Inc. | Jun 2, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
| RXDX | Prometheus Biosciences, Inc. | May 19, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| CADL | Candel Therapeutics, Inc. | Dec 8, 2022 | 2 | $73.1K | 4 | Dec 12, 2022 | Director |
| CADL | Candel Therapeutics, Inc. | Aug 8, 2022 | 1 | $0 | 4 | Aug 10, 2022 | Director |
| CADL | Candel Therapeutics, Inc. | Aug 8, 2022 | 0 | $0 | 3 | Aug 10, 2022 | Director |
| RXDX | Prometheus Biosciences, Inc. | May 19, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| BHC | Bausch Health Companies Inc. | May 10, 2022 | 10 | -$3.76M | 4 | May 12, 2022 | Director |
| BLCO | Bausch & Lomb Corp | May 5, 2022 | 2 | $0 | 4 | May 9, 2022 | CEO & Chairman, Director |
| BLCO | Bausch & Lomb Corp | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | Chief Executive Officer and Chairman Exhibit 24 - Power of Attorney, Director |
| BHC | Bausch Health Companies Inc. | Mar 3, 2022 | 1 | -$299K | 4 | Mar 7, 2022 | CHAIRMAN & CEO, Director |
| BHC | Bausch Health Companies Inc. | Feb 26, 2022 | 7 | -$8.28M | 4 | Mar 2, 2022 | Chairman & CEO, Director |
| RXDX | Prometheus Biosciences, Inc. | Nov 14, 2021 | 1 | $0 | 4 | Nov 16, 2021 | Director |
| BHC | Bausch Health Companies Inc. | Sep 13, 2021 | 2 | -$247K | 4 | Sep 15, 2021 | CHAIRMAN & CEO, Director |